We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Pleural Fluid pH Measured with Blood Gas Analyzer

By LabMedica International staff writers
Posted on 24 Jun 2013
The measurement of pleural fluid pH can be a clinically useful tool in the management of patients with parapneumonic effusions, which may be a symptom of underlying illness.

Pleural fluid pH testing is now offered on the RAPIDPoint 500 Blood gas system, providing US laboratories and point-of-care coordinators with an important new diagnostic tool for critical care situations. More...
RAPIDPoint 500 Blood Gas Analyzers deliver accurate, laboratory-quality test results from a single sample and for multiple sample types (pleural fluids, whole blood, or dialysate fluids).

Siemens Healthcare Diagnostics (Tarrytown, NY, USA) has obtained US Food and Drug Association (FDA; Atlanta GA, USA) clearance to offer pleural fluid pH testing on its RAPIDPoint 500 Blood Gas System. The addition of pleural fluid pH testing on the company’s RAPIDPoint 500 System complements the analyzer’s comprehensive critical care menu, which includes tests for blood gases, electrolytes, glucose, lactate, and full CO-oximetry, including neonatal total bilirubin and total hemoglobin.

When a patient’s pleural fluid pH is less than 7.30 (normal pleural fluid pH is estimated at 7.64), it may imply the presence of an inflammatory or infiltrative process. These measurements can be taken using pH meters or indicator sticks, but multiple studies have shown that these methods are less accurate than readings conducted with blood gas analyzers. The American College of Chest Physicians (ACCP) recommends blood gas analyzers as the preferred pleural fluid chemistry test for categorizing and managing parapneumonic effusions.

The RAPIDPoint 500 system leverages Siemens technology to deliver laboratory-quality results in approximately 60 seconds from a single, whole blood sample. In addition, the analyzer’s measurement cartridges last up to 28 days and contain a full complement of tests, reducing downtime.

Related Links:

Siemens Healthcare Diagnostics
US Food and Drug Association



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.